ArticleInternational journal of retina and vitreous2026
Postoperative cystoid macular edema after pars plana vitrectomy for epiretinal membrane: incidence, anatomical and functional outcomes, and response to intravitreal dexamethasone implant.
Article in International journal of retina and vitreous, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundTo determine the incidence of postoperative cystoid macular edema (CME) following pars plana vitrectomy (PPV) with epiretinal membrane (ERM) peeling, and to evaluate the anatomical and functional response to intravitreal dexamethasone implant (Ozurdex; AbbVie) in affected eyes.
methodsThis retrospective, single-center cohort study included 92 consecutive eyes with idiopathic ERM that underwent PPV with ERM peeling by a single surgeon. Eyes were allocated to a control group (n = 84), comprising eyes without postoperative CME, or to a CME group (n = 8), comprising eyes that developed postoperative CME confirmed on swept-source optical coherence tomography (SS-OCT) and subsequently received intravitreal dexamethasone implant (DEX). Best-corrected visual acuity (BCVA, logMAR), central macular thickness (CMT, µm), and intraocular pressure (IOP, mmHg) were assessed preoperatively and postoperatively in both groups, and before and after DEX implantation in the CME group.
resultsThe incidence of postoperative CME requiring treatment was 8.7%. Most baseline characteristics were comparable between groups, although preoperative IOP was significantly lower in the CME group. CMT decreased significantly after surgery in both the control group (335.1 ± 37.3 to 289.5 ± 22.9 μm; p < 0.001) and the CME group (382.9 ± 74.6 to 310.9 ± 22.9 μm; p = 0.033); however, postoperative CMT remained significantly higher in the CME group than in controls (p = 0.034). DEX implantation produced an additional significant CMT reduction (379.9 ± 67.1 to 302.7 ± 35.3 μm; p = 0.003), reducing the between-group difference to a non-significant level (p = 0.332). BCVA improved significantly after surgery in the control group (0.32 ± 0.26 to 0.04 ± 0.10 logMAR; p < 0.001) but not in the CME group (p = 0.582). Following DEX implantation, BCVA improved significantly in the CME group (0.47 ± 0.35 to 0.22 ± 0.25 logMAR; p = 0.002), approaching values observed in the control group (p = 0.078). IOP remained stable in controls (p = 0.576). A transient but significant IOP increase was observed in the CME group after surgery (11.5 ± 2.7 to 15.3 ± 3.7 mmHg; p = 0.019), with no further change after DEX implantation (p = 0.747).
conclusionsPostoperative CME requiring treatment occurred in approximately 1 in 11 eyes following PPV with ERM peeling and was associated with significant anatomical and functional impairment. The present findings suggest that intravitreal dexamethasone implant was associated with improvement in selected cases of postoperative CME without additional impact on IOP; however, larger prospective studies are required to confirm these results.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.